Sixtus Allert1, Thomas Kremer2, Bernd Halbe3
1Klinik für Plastische und Ästhetische Chirurgie, Handchirurgie, Sana Klinikum Hameln-Pyrmont, Hameln.
Lawsuits are increasing for patients with Biocell breast implants due to alleged inadequate disclosure of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) risks by surgeons. This highlights the need to define when surgeons should inform patients about potential complications.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: